Coeptis Therapeutics, Inc. (COEP)
USD 0.18
(-16.07%)
USD 0.18
(-16.07%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.22 Million USD | -28.25% |
| 2022 | 1.7 Million USD | -58.2% |
| 2021 | 4.08 Million USD | 95.5% |
| 2020 | 2.08 Million USD | 1267.78% |
| 2019 | 152.64 Thousand USD | 145.91% |
| 2018 | 62.07 Thousand USD | 0.0% |
| 2005 | 650 Thousand USD | 584.21% |
| 2004 | 95 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.42 Million USD | 98.3% |
| 2024 Q2 | 1.78 Million USD | -26.49% |
| 2023 FY | 1.22 Million USD | -28.25% |
| 2023 Q3 | 1 Million USD | -50.86% |
| 2023 Q4 | 1.22 Million USD | 22.36% |
| 2023 Q2 | 2.03 Million USD | 20.03% |
| 2023 Q1 | 1.69 Million USD | -0.59% |
| 2022 Q3 | 3.83 Million USD | -1.42% |
| 2022 FY | 1.7 Million USD | -58.2% |
| 2022 Q4 | 1.7 Million USD | -55.48% |
| 2022 Q1 | 3.9 Million USD | -4.4% |
| 2022 Q2 | 3.88 Million USD | -0.35% |
| 2021 Q1 | 1.75 Million USD | 0.0% |
| 2021 FY | 4.08 Million USD | 95.5% |
| 2021 Q4 | 4.08 Million USD | 2.05% |
| 2021 Q3 | 3.99 Million USD | 433.57% |
| 2021 Q2 | 749.59 Thousand USD | -57.39% |
| 2020 FY | 2.08 Million USD | 1267.78% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 FY | 152.64 Thousand USD | 145.91% |
| 2018 FY | 62.07 Thousand USD | 0.0% |
| 2005 FY | 650 Thousand USD | 584.21% |
| 2005 Q4 | 650 Thousand USD | 49.49% |
| 2005 Q2 | 434.8 Thousand USD | 357.68% |
| 2005 Q3 | 434.8 Thousand USD | 0.0% |
| 2005 Q1 | 95 Thousand USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | 95 Thousand USD | 0.0% |
| 2004 FY | 95 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 97.029% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 70.3% |
| SQZ Biotechnologies Company | 27.47 Million USD | 95.544% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 97.177% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 95.887% |
| Mesoblast Limited | 118.7 Million USD | 98.969% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -29.101% |
| Genus plc | 233.1 Million USD | 99.475% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 58.223% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 8.884% |
| Marizyme, Inc. | 18.71 Million USD | 93.459% |
| ContraFect Corporation | 2.88 Million USD | 57.507% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -63.23% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -803.575% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | 15.356% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | 47.367% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 78.364% |
| MultiCell Technologies, Inc. | 202.58 USD | -604217.307% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 97.871% |
| EV Biologics, Inc. | 1.49 Million USD | 18.098% |
| Q BioMed Inc. | 4.1 Million USD | 70.213% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 96.302% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -94.298% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | 0.337% |
| Biomind Labs Inc. | 735.54 Thousand USD | -66.439% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 99.286% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 90.581% |
| Skye Bioscience, Inc. | 4.61 Million USD | 73.474% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -37.853% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -765.067% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 79.148% |
| IMV Inc. | 28.88 Million USD | 95.762% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -4660.006% |
| Curative Biotechnology, Inc. | 2.25 Million USD | 45.792% |
| GB Sciences, Inc. | 1.75 Million USD | 30.414% |
| Alpha Cognition Inc. | 1.22 Million USD | -0.316% |
| HST Global, Inc. | 98.31 Thousand USD | -1145.157% |
| CSL Limited | 12.18 Billion USD | 99.99% |
| Halberd Corporation | 150 Thousand USD | -716.151% |
| Enzolytics Inc. | 996.33 Thousand USD | -22.873% |
| Resverlogix Corp. | 6.49 Million USD | 81.14% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -156.382% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -378.977% |
| argenx SE | 20 Million USD | 93.879% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 97.313% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 54.804% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -11872.87% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.707% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -510.233% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | 48.942% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -433.918% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 98.19% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 59.546% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -240.337% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 93.978% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -723.541% |
| BioStem Technologies, Inc. | 4.71 Million USD | 74.016% |
| ONE Bio Corp. | 19.71 Million USD | 93.79% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -389.334% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -392.211% |
| Agentix Corp. | 50 Thousand USD | -2348.452% |
| LadRx Corporation | 33.6 Thousand USD | -3542.879% |
| Cell Source, Inc. | 9.25 Million USD | 86.771% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -61.891% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -61.891% |
| NovAccess Global Inc. | 2.19 Million USD | 44.35% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 82.691% |
| Itoco Inc. | 228.37 Thousand USD | -436.055% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -480.271% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 75.432% |
| Kadimastem Ltd | 891.22 Thousand USD | -37.364% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -204.648% |
| CytoDyn Inc. | 30.07 Million USD | 95.93% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -152.791% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -247.943% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 84.345% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -899.368% |
| Rebus Holdings, Inc. | 310 Thousand USD | -294.912% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 74.147% |
| International Stem Cell Corporation | 4.17 Million USD | 70.698% |
| Bioxytran, Inc. | 1.92 Million USD | 36.404% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1861.492% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 43.866% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 85.279% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 85.74% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | 21.296% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -356.801% |
| Neutra Corp. | 54.15 Thousand USD | -2160.555% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | 33.102% |
| PureTech Health plc | 25.51 Million USD | 95.201% |
| IXICO plc | 472.02 Thousand USD | -159.357% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 92.102% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 98.034% |
| CSL Limited | 12.18 Billion USD | 99.99% |
| Cellectis S.A. | 92.77 Million USD | 98.68% |